Volume : 13, Issue : 09, September – 2026
Title:
A PROSPECTIVE STUDY ON EFFECT OF CEPHALOSPORIN IN BACTERIAL INFECTION
Authors :
Yerra Praveena, Ch. Sunitha
Abstract :
Most bacteria aren’t harmful. In fact, we have many bacteria inside our body and on our skin. Bacteria in our intestines (gut) help us to digest our food. But some bacteria can cause infections. Bacterial infections can affect many parts of your body, including. A bacterium is a single, but complex, cell. It can survive on its own, inside or outside the body. Escherichia coli is the second cause of bacterial meningitis in neonates. Despite the use for 35 years of third-generation cephalosporins, high morbidity and mortality rates with E. coli meningitis continue to occur. Because cephalosporins has good microbiologic activity against E. coli and good penetration in cerebrospinal fluid and brain. Antibiotic therapy recommended for meningitis due to E. coli like third generation cephalosporin.. However, drawbacks are low tissue penetration and reduced bactericidal activity on microorganisms in the stationary phase. Corticosteroids are not currently recommended in the treatment of neonatal meningitis All neonates (<1 month of age) and infants ( Keywords: Escherichia coli, Cephalosporins, pharmacokinetics, pharmacodynamics, CSF.
Cite This Article:
Please cite this article in press Yerra Praveena et al., A Prospective Study On Effect Of Cephalosporin In Bacterial Infection.,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. “coli”. Oxford English Dictionary (Online ed.). Oxford University Press. (Subscription or participating institution membership required.)
2. Wells, J. C. (2000) Longman Pronunciation Dictionary. Harlow [England], Pearson Education Ltd.
3. Tenaillon O, Skurnik D, Picard B, Denamur E (March 2010). “The population genetics of commensal Escherichia coli”. Nature Reviews. Microbiology. 8 (3): 207–17.
4. Singleton P (1999). Bacteria in Biology, Biotechnology and Medicine (5th ed.). Wiley. pp. 444–54.
5. “Escherichia coli”. CDC National Center for Emerging and Zoonotic Infectious Diseases. Retrieved 2 October 2012.
6. Vogt RL, Dippold L (2005). “Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June–July 2002”. Public Health Reports. 120 (2): 174–78.
7. Martinson JNV, Walk ST (2020). “Escherichia coli residency in the gut of healthy human adults”. EcoSal Plus. 9 (1).
8. Bentley R, Meganathan R (September 1982). “Biosynthesis of vitamin K (menaquinone) in bacteria”. Microbiological Reviews. 46 (3): 241–80.
9. Hudault S, Guignot J, Servin AL (July 2001). “Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection”. Gut. 49 (1): 47–55.
10. Reid G, Howard J, Gan BS (September 2001). “Can bacterial interference prevent infection?”. Trends in Microbiology. 9 (9): 424–28.